BMS 707035
BMS 707035 Uses, Dosage, Side Effects, Food Interaction and all others data.
BMS 707035 is under investigation in clinical trial NCT00397566 (A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects).
Trade Name | BMS 707035 |
Generic | HIV Integrase Inhibitor |
HIV Integrase Inhibitor Other Names | BMS 707035 |
Type | |
Formula | C17H19FN4O5S |
Weight | Average: 410.42 Monoisotopic: 410.106019065 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here BMS 707035